A report from the American Academy of Pediatrics (AAP) published in the journal Pediatrics cautions pregnant women and nursing mothers to avoid marijuana use due to possible adverse developmental effects to their baby. In a study reviewed for the report, short-term exposure to CBD was found to increase the permeability of the placental barrier, potentially placing the fetus at risk from certain substances.
Serotonin is a neurotransmitter that affects mood, social behavior, sleep, memory, appetite, and sexual function. It is believed that anxiety and depression occur when the brain isn’t properly using serotonin. 5-HT1A is a subtype of serotonin receptor, and CBD oil enhances 5-HT1A transmission. This allows for your brain to make use of the serotonin in the synaptic space, instead of it just going back into the brain. This is what makes CBD oil regulate your mood and reduce anxiety.
^ Hayakawa K, Mishima K, Hazekawa M, Sano K, Irie K, Orito K, Egawa T, Kitamura Y, Uchida N, Nishimura R, Egashira N, Iwasaki K, Fujiwara M (January 2008). "Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism". Brain Research. 1188: 157–64. doi:10.1016/j.brainres.2007.09.090. PMID 18021759.
CBD oil isn’t legal everywhere. In the United States, some states allow it for only specific medical purposes and some don’t. You may need to get a license from your doctor to be able to use CBD. If cannabis is approved for medical use in your state, you may be able to purchase CBD oil online or in special cannabis stores or clinics. As research on CBD continues, more states may consider the legalization of cannabis products.

Anxiety-related disorders affect a huge segment of our population—40 million adults (18%) in the United States age 18 and older. In response, Big Pharma has developed numerous drugs to treat anxiety-related disorders, from selective serotonin reuptake inhibitors (SSRIs) like Prozac and Zoloft to tranquilizers (the most popular class being benzodiazepines such as Valium and Xanax).


Anxiety Disorder Association of America (ADAA) conducts research every year to find out the statistics increase or decrease. The studies conducted over a period of 10 years have revealed that 54 percent of the women while 46 percent of the men suffer from the anxiety disorders. But some studies also believe that the numbers of men who suffer from the anxiety issues are much higher than that of the women. It is just that they do not report their problem to the doctors or do not seek out for help until something significant problem occurs.
Good morning! Reading through your article, I'm completely impressed and thinking of the various clinical applications (that depressed patient, that anxious one, my arthritic knees!) for the CBD's. THEN you talk about your product, the combination of co-factors sounding really great, but the nano-particles alarm me. There is a fair amount of research about the hazards of nano-particles in cleaning and cosmetic products, I'm wary of ingesting them for fear of nano-sized items going afield of where I'm intending them to go.
Good morning! Reading through your article, I'm completely impressed and thinking of the various clinical applications (that depressed patient, that anxious one, my arthritic knees!) for the CBD's. THEN you talk about your product, the combination of co-factors sounding really great, but the nano-particles alarm me. There is a fair amount of research about the hazards of nano-particles in cleaning and cosmetic products, I'm wary of ingesting them for fear of nano-sized items going afield of where I'm intending them to go.
For example, CBD can increase CB1 receptor density so that there’s just too many CB1 receptors for THC to bind to, thus taking the edge off the potential psychoactivity of weed, while still retaining all the opioid-like painkilling effects. In case you are concerned about this meaning you have to buy more weed or take more hits if you’re using CBD oil, you should also know that CBD can extend the duration of the effects of THC by inhibiting the cytochrome P-450 enzymes that would cause you to more rapidly metabolize THC.

Accordingly, CB1R activation has been suggested as a target for anxiolytic drug development [15, 43, 44]. Proposed agents for enhancing CB1R activation include THC, which is a potent and direct agonist; synthetic CB1R agonists; FAAH inhibitors and other agents that increase eCB availability, as well as nonpsychoactive cannabis phytocannabinoids, including CBD. While CBD has low affinity for the CB1R, it functions as an indirect agonist, potentially via augmentation of CB1R constitutional activity, or via increasing AEA through FAAH inhibition (reviewed in [21]).

Best known for their role in beer brewing, the female flowers of hop are being increasingly used in supplements for insomnia, anxiety, and menopausal symptoms. In addition, research on their components has revealed new activities with promising clinical applications. Read below to learn more about hops’ components, health benefits, side effects, and interactions with drugs […]
Leonard Leinow has three decades of experience growing and studying medical cannabis and brings a unique spiritual perspective to his work. In 2009, he formed Synergy Wellness, a not-for-profit medical cannabis collective in California. Synergy Wellness has over 3,500 members in its collective and is an artisan organization making hand-crafted organic and natural whole plant-based products. They are specialists in CBD (cannabidiol), the non-psychoactive portion of cannabis, and are pioneers in this aspect of the industry. Leinow is known for his proprietary blends of tinctures and medicine used for cancer and epilepsy patients.
Following cloning of the endogenous receptor for THC, namely the CB1R, endogenous CB1R ligands, or “endocannabinoids” (eCBs) were discovered, namely anandamide (AEA) and 2-arachidonoylglycerol (reviewed in [22]). The CB1R is an inhibitory Gi/o protein-coupled receptor that is mainly localized to nerve terminals, and is expressed on both γ-aminobutryic acid-ergic and glutamatergic neurons. eCBs are fatty acid derivatives that are synthesized on demand in response to neuronal depolarization and Ca2+ influx, via cleavage of membrane phospholipids. The primary mechanism by which eCBs regulate synaptic function is retrograde signaling, wherein eCBs produced by depolarization of the postsynaptic neuron activate presynaptic CB1Rs, leading to inhibition of neurotransmitter release [23]. The “eCB system” includes AEA and 2-arachidonoylglycerol; their respective degradative enzymes fatty acid amide hydroxylase (FAAH) and monoacylglycerol lipase; the CB1R and related CB2 receptor (the latter expressed mainly in the periphery); as well as several other receptors activated by eCBs, including the TRPV1 receptor, peroxisome proliferator-activated receptor-γ, and G protein-coupled 55 receptor, which functionally interact with CB1R signaling (reviewed in [21, 24]). Interactions with the TRPV1 receptor, in particular, appear to be critical in regulating the extent to which eCB release leads to inhibition or facilitation of presynaptic neurotransmitter release [25]. The TRPV1 receptor is a postsynaptic cation channel that underlies sensation of noxious heat in the periphery, with capsacin (hot chili) as an exogenous ligand. TRPV1 receptors are also expressed in the brain, including the amygdala, periaqueductal grey, hippocampus, and other areas [26, 27].
For people who suffer from insomnia, constant anxiety during the night or simply struggle to get a sound, restful night of undisturbed sleep, cannabis sativa essential oil may work like a charm. However, according to a research report published by Dr. Ethan Russo, Director of Research for the International Cannabis and Cannabinoids Institute, terpenoids produce an “entourage effect”.
×